MAPT and Alzheimer disease: Notably, Fyn‐knockout AD transgenic mice (Tg/fyn−/−) show a significant reduction in both Tau accumulation and Tau‐induced neuropathology, further supporting Fyn's critical role in AD pathogenesis [203].